ZulYusmar.com - Top 40 Malaysia Lifestyle, Technology, F&B, Travel & Business Online Portal

AstraZeneca’s Evusheld (tixagevimab and cilgavimab, MAL 22056042ACR2), a monoclonal antibody combination, has been launched today in Malaysia’s private hospitals for the prevention of COVID-19 in high-risk individuals. Dr. Sanjeev Panchal, Associate Professor Dr. Adli Ali, Consultant Paediatric Immunologist, and Mr Saravanan Valiatham, patient advocate for Malaysian Patient Organisation for Primary Immunodeficiencies, MyPOPI, at a panel discussion speaking on the new preventive option for high-risk individuals. The National Pharmaceutical Regulatory Agency (NPRA) had granted conditional registration for Evusheld in May this year for the pre-exposure prophylaxis (prevention) of COVID-19 in adults and adolescents aged 12 years and older weighing at least 40kg who are unlikely to mount an adequate immune response to COVID-19 vaccination, or for whom COVID-19 vaccination is not recommended. Evusheld’s introduction to Malaysia’s private market means that the most vulnerable individual...

AstraZeneca announced today the launch of its Severe Asthma awareness campaign entitled, ‘Listen To Your Asthma’, in collaboration with Asthma Malaysia and Brand Ambassador Dina Nadzir, singer and radio announcer, sharing her personal journey as an asthma patient. The Listen To Your Asthma campaign is to help educate and raise awareness about severe asthma so that those suffering from severe asthma symptoms can get the right diagnosis and treatment to lead a better quality of life. Knowing Severe Asthma Severe Asthma is a chronic, inflammatory condition that affects the airways to the lungs and does not respond to commonly prescribed medication for regular asthma. It is a long-term condition where tiny muscles around the breathing airways tighten and the walls swell up, leading to smaller-sized tubes channelling air into the lungs. This leads to a drop in the amount of oxygen that goes into the body. Severe Asthma has a number of symptoms, and one of the most common symptoms is wheezin...